Modulation of HLA-G antigens expression in myelomonocytic cells

被引:44
作者
Onno, M
Le Friec, G
Pangault, C
Amiot, L
Guilloux, V
Drénou, B
Caulet-Maugendre, S
André, P
Fauchet, R
机构
[1] INSERM, CRI 9606, Fac Med, Lab Univ Hematol & Biol Cellules Sanguines, Rennes, France
[2] Anat Pathol Lab, Rennes, France
[3] Ecole Normale Super, INSERM, U503, Lyon, France
关键词
HLA-G antigens; macrophages; tolerance; human cytomegalovirus; inflammation;
D O I
10.1016/S0198-8859(00)00191-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As trophoblast cells and macrophages share cellular characteristics, we investigated the expression of HLA-G antigens during the myelomonocytic differentiation. Analyses with the 87G and 16G1 monoclonal antibodies demonstrated that HLA-G was not expressed in peripheral blood monocytes, in in vitro differentiated dendritic cells and macrophages, and in resident mononuclear phagocytes infiltrating healthy tissues. Conversely, activated macrophages and dendritic cells localized in tumoral biopsies of some lung carcinomas expressed HLA-G antigens. Induction of HLA-G expression at the cell surface of the monohistiocytic cell line U 937 with different cytokines strongly suggests that cytokines secreted during inflammation may be involved in this specific upregulation. Bronchoalveolar macrophages collected from patients suffering from acute HCMV pneumonitis also expressed HLA-G molecules. In vitro, we thus demonstrated that HLA-G antigens are produced during viral reactivation in the macrophages generated after allogeneic stimulation of HCMV latently infected monocytes. Our data suggest that inflammatory processes in lung tissues, like tumoral transformation and HCMV acute infection, are likely to induce HLA-G molecules in infiltrating macrophages and dendritic cells. The expression of molecules capable of downregulating both the innate and adoptive immunity could be a mechanism that helps tumoral and HCMV infected cells to escape immune response. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:1086 / 1094
页数:9
相关论文
共 16 条
[1]   Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells [J].
Allan, DSJ ;
Colonna, M ;
Lanier, LL ;
Churakova, TD ;
Abrams, JS ;
Ellis, SA ;
McMichael, AJ ;
Braud, VM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1149-1155
[2]   MECHANISMS OF IMMUNOSUPPRESSION IN CYTOMEGALO-VIRUS MONONUCLEOSIS .2. VIRUS-MONOCYTE INTERACTIONS [J].
CARNEY, WP ;
HIRSCH, MS .
JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (01) :47-54
[3]   HLA-G: a tolerance molecule from the major histocompatibility complex [J].
Carosella, ED ;
Rouas-Freiss, N ;
Paul, P ;
Dausset, J .
IMMUNOLOGY TODAY, 1999, 20 (02) :60-62
[4]   Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J].
Fournel, S ;
Aguerre-Girr, M ;
Huc, X ;
Lenfant, F ;
Alam, A ;
Toubert, A ;
Bensussan, A ;
Le Bouteiller, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6100-6104
[5]   QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS VIREMIA BY USING MONOCLONAL-ANTIBODIES TO DIFFERENT VIRAL-PROTEINS [J].
GERNA, G ;
REVELLO, MG ;
PERCIVALLE, E ;
ZAVATTONI, M ;
PAREA, M ;
BATTAGLIA, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) :2681-2688
[6]   Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease [J].
Krause, H ;
Hebart, H ;
Jahn, G ;
Muller, CA ;
Einsele, H .
BONE MARROW TRANSPLANTATION, 1997, 19 (11) :1111-1116
[7]   Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time [J].
Larsson, S ;
Söderberg-Nauclér, C ;
Wang, FZ ;
Möller, E .
TRANSFUSION, 1998, 38 (03) :271-278
[8]  
Le Bouteiller P, 1997, EUR J IMMUNOGENET, V24, P399
[9]   HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes [J].
Le Gal, FA ;
Riteau, B ;
Sedlik, C ;
Khalil-Daher, I ;
Menier, C ;
Dausset, J ;
Guillet, JG ;
Carosella, ED ;
Rouas-Freiss, N .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (08) :1351-1356
[10]  
Lee L. T., 1995, PAC REV, V8, P531